Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease.
Behav Brain Res
; 223(1): 70-4, 2011 Sep 30.
Article
in En
| MEDLINE
| ID: mdl-21540059
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parkinson Disease, Secondary
/
Behavior, Animal
/
4-Aminopyridine
/
Oxidopamine
/
Tetraethylammonium
/
Potassium Channel Blockers
Type of study:
Prognostic_studies
Aspects:
Patient_preference
Limits:
Animals
Language:
En
Journal:
Behav Brain Res
Year:
2011
Document type:
Article
Affiliation country:
Iran